Navigation Links
S.C. BlueCross Launches Less-Costly Plans Geared to Groups Seeking More Options
Date:6/16/2008

COLUMBIA, S.C., June 16 /PRNewswire-USNewswire/ -- BlueCross BlueShield of South Carolina this month introduces Blue Spectrum(SM), a rebranding of the company's health insurance plans that also adds less-costly plans designed for groups and individuals seeking more options.

"With increasing health care costs forcing rising premium prices, some individuals and employers are either dropping their insurance or not picking it up to begin with," said BlueCross BlueShield Division President David Pankau. "With the introduction of a variety of new product designs, we are providing options that might help companies continue to provide health insurance coverage."

Blue Spectrum eventually will include several layers of health plan options for small group employers and individuals. Business Blue(SM) is a series of plans for groups of two to 50 employees, and Personal Blue(SM) plans accommodate individuals. Three group products are now available under Business Blue: Business Blue(SM) Complete, a full coverage plan; Business Blue(SM) HDHP; and a new plan called Business Blue(SM) Secure.

Business Blue Secure offers similar coverage but adds cost reduction factors that allow for a lower premium. It addresses the needs of employees who want a plan with good benefits, and it helps the employer in balancing coverage and costs.

Later this year, additional plans will be introduced under the Blue Spectrum portfolio, including the first new individual plans to be offered by BlueCross in over 10 years. The new plans include:

-- Business Blue(SM) Basic and Personal Blue(SM) Basic, which offer the

lowest premiums and meet basic insurance needs, such as access to health

care without fear of large medical bills.

-- An individual plan available for local chambers of commerce members

called Personal True Blue(SM), an addition to the existing group plans

available to chamber members.
'/>"/>

SOURCE BlueCross BlueShield of South Carolina
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
2. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
3. Harvard Researchers Select S.C. BlueCross for National Honor
4. National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts
5. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
6. BlueCross Receives Federal Approval for 2008 Medicare Plans
7. American Heart Association Honors Regence BlueCross BlueShield of Utah as the States First Start! Fit-Friendly Company
8. Empire BlueCross BlueShield Announces Release of State Health Index Data
9. Empire BlueCross BlueShield and New York Attorney General Reach Agreement on Guidelines for State Doctor Ranking Programs
10. S.C. BlueCross BlueShield Receives URAC Case Management Accreditation
11. S.C. BlueCross, BlueChoice HealthPlan Expand Global Offerings to Include Dental Services
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Partnership for a Drug-Free America(R) Responds to 2008 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2008 Monitoring the Future Study Results 3Health News:Betty White's Video States Support for Funding Humane Research to Help Pets and Wild Animals - Actress is 40-Year Champion of Morris Animal Foundation 2Health News:Hallmark Hall of Fame Collaboration with Patient Organization Equals Extraordinary Success 2Health News:Playing Video Games May Boost Older Brains 2Health News:Playing Video Games May Boost Older Brains 3Health News:Cancer drugs in the pipeline 2Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 2Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 3Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 4Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 5Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 6Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 7
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 57495 1SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 57495 2SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 57495 3SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 57495 4SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 57495 5SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 57495 6African Americans at Significantly Higher Risk of DVT or Blood Clots 57491 1African Americans at Significantly Higher Risk of DVT or Blood Clots 57491 2African Americans at Significantly Higher Risk of DVT or Blood Clots 57491 3African Americans at Significantly Higher Risk of DVT or Blood Clots 57491 4Rigel Announces Pricing of Public Offering of 13 000 000 Shares of Common Stock 14119 1Rigel Announces Pricing of Public Offering of 13 000 000 Shares of Common Stock 14119 2